Endo in a Bite

2026 Consensus Statement on the Use of Diabetes Technology for Management of Adults with Diabetes (Part 6)

In this episode, we review the 2026 Consensus Statement on the use of diabetes technology for management of adults with diabetes, focusing on automated insulin delivery b

2026 Consensus Statement on the Use of Diabetes Technology for Management of Adults with Diabetes (Part 5)

In this episode, we review the 2026 Consensus Statement on the use of diabetes technology for management of adults with diabetes, focusing on automated insulin delivery.

2026 Consensus Statement on the Use of Diabetes Technology for Management of Adults with Diabetes (Part 4)

In this episode, we review the 2026 Consensus Statement on the use of diabetes technology for management of adults with diabetes, focusing on continuous glucose monitorin

2026 Consensus Statement on the Use of Diabetes Technology for Management of Adults with Diabetes (Part 3)

In this episode, we review the 2026 Consensus Statement on the use of diabetes technology for management of adults with diabetes, focusing on continuous glucose monitorin

2026 Consensus Statement on the Use of Diabetes Technology for Management of Adults with Diabetes (Part 2)

In this episode, we review the 2026 Consensus Statement on the use of diabetes technology for management of adults with diabetes, focusing on continuous glucose monitorin

2026 Consensus Statement on the Use of Diabetes Technology for Management of Adults with Diabetes (Part 1)

In this episode, we review the 2026 Consensus Statement on the use of diabetes technology for management of adults with diabetes, focusing on continuous glucose monitorin

GAD65, IAA, IA-2, And ZnT8: Islet Autoantibodies in Type 1 Diabetes

In this episode, we review the major islet autoantibodies used in type 1 diabetes, focusing on GAD65 in adults, IAA in young children, IA-2 and progression risk, and ZnT8

The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Selecting Glucose Lowering Therapy

In this episode, we review the 2026 Consensus Statement algorithm for selecting glucose lowering therapy in adults with type 2 diabetes, focusing on cardiovascular, heart

The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Insulin Management (Part 3)

In this episode, we review the 2026 Consensus Statement algorithm for insulin management in adults with type 2 diabetes, focusing on the transition beyond basal insulin.

The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Insulin Management (Part 2)

In this episode, we review the 2026 Consensus Statement algorithm for insulin management in adults with type 2 diabetes, focusing on basal insulin initiation and titratio

The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Insulin Management (Part 1)

In this episode, we review the 2026 Consensus Statement algorithm for insulin management in adults with type 2 diabetes. Topics include individualized glycemic targets, t

The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Glucose Centric Management (Episode 10)

In this episode, we review the 2026 Consensus Statement algorithm for glucose centric management in adults with type 2 diabetes. Topics include identifying patients appro

The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Metabolic Dysfunction Associated Steatotic Liver Disease (Episode 9)

In this episode, we review the 2026 Consensus Statement algorithm for metabolic dysfunction associated steatotic liver disease (MASLD) management in adults with type 2 di

The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Stroke and Transient Ischemic Attack (Episode 8)

In this episode, we review the 2026 Consensus Statement algorithm for stroke and transient ischemic attack management in adults with type 2 diabetes. Topics include strok

The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Atherosclerotic Cardiovascular Disease Management (Episode 7)

In this episode, we review the 2026 Consensus Statement ASCVD management algorithm for adults with Type 2 Diabetes. Topics include cardiovascular risk reduction, major ad

The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Chronic Kidney Disease Management (Episode 6)

In this episode, we review the 2026 Consensus Statement algorithm for the management of chronic kidney disease in adults with Type 2 Diabetes. Topics include SGLT2 inhibi

The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Heart Failure Management (Episode 5)

In this episode, we review the 2026 Consensus Statement algorithm for heart failure management in adults with Type 2 Diabetes. Topics include the foundational role of SGL

The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Hypertension Management (Episode 4)

In this episode, we review the 2026 Consensus Statement hypertension algorithm for adults with Type 2 Diabetes. Topics include blood pressure targets, screening for secon

The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Lipid Management (Episode 3)

In this episode, we review the 2026 Consensus Statement on Lipid Management in Adults with Type 2 Diabetes. Topics include ASCVD risk assessment, LDL-C treatment targets,

The 2026 Consensus Statement on Diabetes Classification in Adults (Episode 2)

In this episode, we review the 2026 Consensus Statement on Diabetes Classification in Adults. Topics include diagnostic criteria for diabetes, distinguishing type 2 diabe